Annual Multicancer Early Detection Test Not Associated with a Lower Incidence Rate of Stage III or IV Cancer After Three Screening Rounds and 12 Months of Follow-Up By Ogkologos - October 1, 2026 8 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the the NHS-Galleri study Source RELATED ARTICLESMORE FROM AUTHOR European Parliament Report on Europe’s Beating Cancer Plan Strengthens Commitment to Rare Cancer Care Beginning Surveillance Colonoscopy After 5 Years from Removal of High-Risk Adenomas Non-inferior than at 3 Years in Terms of Cumulative CRC Incidence Tambotatug Pelitecan Leads to Better Clinical Outcomes than Topotecan Among Patients with Relapsed SCLC After Platinum-based Therapy MOST POPULAR As Winter Storms Plague Southern States, GreaterGood Is Helping Where It’s... February 25, 2021 Adjuvant Pembrolizumab Continues to Demonstrate a Clinically Meaningful DMFS Benefit in... March 14, 2024 2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in... June 7, 2022 Adjuvant Selpercatinib Prolongs EFS Among Patients with Stage II or IIIA... June 2, 2026 Load more HOT NEWS EMA Recommends Granting a Conditional Marketing Authorisation for Mirdametinib After Being Told a Lump Was Benign, Teenager Learns She Has... How Wartime Violence Against Women Is Hurting Millions Worldwide Can Using Hair Dyes or Hair Relaxers Impact Your Cancer Risk?
